Reuters reports that China is considering taking measures that will shorten the time to market for approved imported drugs in an effort to ease a shortage of such medicines, according to the China Food and Drug Administration (CFDA). The proposed changes to current clinical trial requirements were in response to public demand for new drugs, […]
Category: Health Care
China’s two-child policy is showing “notable results” with the fertility rate expected to rise through to 2020, a senior health official said on Saturday. Speaking to reporters on the sidelines of China’s annual meeting of parliament, Wang Peian, vice-minister of the National Health and Family Planning Commission said there were “notable results” in 2016, with […]
China’s Shanghai Fosun Pharmaceutical is planning a bid for German generic drugmaker Stada, already the center of a 3.6 billion euro ($3.8 billion) takeover battle between two private equity consortia, two people close to the matter told Reuters. Fosun Pharma is also holding early-stage talks with buyout funds including CVC about a potential joint bid, […]
China’s largest drugmaker by market value forecast a revenue surge in the second half of this year as more of its drugs get approved overseas and said it plans to bolster its international presence over time through deals of up to $2 billion. Jiangsu Hengrui Medicine is looking to buy companies making both generic and […]
China is considering introducing birth rewards and subsidies to encourage people to have a second child, after surveys showed that economic constraints were making many reluctant to expand families, Reuters reports. The potential move was revealed by Wang Peian, vice-minister of the National Health and Family Planning Commission at a social welfare conference on Saturday. […]